Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)
CNY 14.14
(-1.6%)
CNY 14.14
(-1.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.21 Billion | 1.24 Billion | 938.42 Million | 1.55 Billion | 1.75 Billion | 67.89 Million |
| Net Income | 817.24 Million | 1.17 Billion | 480.64 Million | 994.59 Million | 606.82 Million | 134.9 Million |
| Depreciation & Amortization | 789.62 Million | 672.01 Million | 563.07 Million | 470.82 Million | 410.65 Million | 345.04 Million |
| Deferred income taxes | 12.55 Million | -73.7 Million | 65.57 Million | -52.17 Million | 32.47 Million | -56.51 Million |
| Stock-based compensation | -2.87 Million | 59.55 Million | 47.46 Million | 5.91 Million | 3.51 Million | 13.52 Million |
| Change in working capital | 148.94 Million | -902.63 Million | -30.18 Million | -229.48 Million | 439.63 Million | -735.25 Million |
| Other non-cash items | 478.69 Million | 311.45 Million | -188.13 Million | 365.78 Million | 260.84 Million | 323.2 Million |
| Investing Cash Flow | -1.62 Billion | -2.43 Billion | -2.35 Billion | -1.35 Billion | -791.05 Million | -1.25 Billion |
| Investments in PPE | -1.59 Billion | -2.31 Billion | -2.43 Billion | -1.27 Billion | -794.3 Million | -1.12 Billion |
| Acquisitions | 4.84 Million | -67.07 Million | 9.93 Million | 32.19 Million | 4.15 Million | - |
| Investment purchases | -87.05 Million | -157.1 Million | -154.43 Million | -116.89 Million | -4.96 Million | -135.86 Million |
| Sales/Maturities of investments | 46.88 Million | 54.24 Million | 218.1 Million | 1.65 Million | 6.06 Million | 104.85 Thousand |
| Other Investing Activities | -18.23 Million | 53.64 Million | 4 Million | 2 Million | -1.99 Million | 3.44 Million |
| Financing Cash Flow | -644.23 Million | 609.04 Million | 1.11 Billion | 596.34 Million | -400.32 Million | 1.35 Billion |
| Debt repayment | -72.56 Million | -2.71 Billion | -1.91 Billion | -5.13 Billion | -250.82 Million | -2.13 Billion |
| Dividends payments | -349.36 Million | -147.28 Million | -290.92 Million | -392.83 Million | -208.88 Million | -308 Million |
| Common Stock Repurchased | -70.99 Million | -172.43 Million | -150.01 Million | - | - | - |
| Common Stock Issuance | - | 37.67 Million | 150.01 Million | - | -6.39 Million | -1.3 Million |
| Other Financing Activities | -147.95 Million | 3.77 Billion | 3.42 Billion | 6.12 Billion | 59.37 Million | 3.79 Billion |
| Accounts receivables | 269.49 Million | -818.89 Million | -388.86 Million | -582.45 Million | 497.17 Million | -345.56 Million |
| Accounts payables | 19.98 Million | 669.88 Million | 679.91 Million | 589.21 Million | 18.79 Million | 342.93 Million |
| Inventory | -140.05 Million | -679.91 Million | -386.81 Million | -184.07 Million | -108.81 Million | -676.11 Million |
| Other working capital | -487.73 Thousand | -73.7 Million | 65.57 Million | -52.17 Million | 32.47 Million | -59.14 Million |
| Cash at beginning of period | 1.36 Billion | 1.85 Billion | 2.19 Billion | 1.48 Billion | 897.52 Million | 677.88 Million |
| Cash at end of period | 1.34 Billion | 1.32 Billion | 1.85 Billion | 2.19 Billion | 1.48 Billion | 897.52 Million |
| Capital Expenditure | -1.59 Billion | -2.31 Billion | -2.43 Billion | -1.27 Billion | -794.3 Million | -1.12 Billion |
| Effect of forex changes on cash | 28.99 Million | 54.65 Million | -43.49 Million | -85.33 Million | 28.69 Million | 53.93 Million |
| Net cash flow / Change in cash | -20.86 Million | -526.18 Million | -343.57 Million | 708.92 Million | 591.25 Million | 219.64 Million |
| Free Cash Flow | 624.63 Million | -1.07 Billion | -1.49 Billion | 278.96 Million | 959.63 Million | -1.05 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 282.7 Million | 477.72 Million | 270.84 Million | 817.24 Million | 104.66 Million | 152.73 Million |
| Depreciation & Amortization | - | 227.18 Million | 227.18 Million | 789.62 Million | 195.74 Million | -386.38 Million |
| Deferred income taxes | - | - | - | 12.55 Million | - | 228.5 Million |
| Stock-based compensation | - | - | - | -2.87 Million | -2.87 Million | -31.94 Million |
| Change in working capital | - | - | - | 148.94 Million | 128.95 Million | 189.82 Million |
| Other non-cash items | 296.91 Million | 194.03 Million | 582.78 Million | 478.69 Million | 195.74 Million | 408.34 Million |
| Investing Cash Flow | -369.87 Million | -343.77 Million | -472.06 Million | -1.62 Billion | -349.74 Million | -335.35 Million |
| Investments in PPE | -345.3 Million | -310.68 Million | -478.28 Million | -1.59 Billion | -337.33 Million | -324.4 Million |
| Acquisitions | 989.14 Thousand | 1.41 Million | 188.27 Thousand | 4.84 Million | 3.16 Million | 524.88 Thousand |
| Investment purchases | -25.52 Million | -34.5 Million | - | -87.05 Million | -41.57 Million | -38 Million |
| Sales/Maturities of investments | - | 49.88 Thousand | 6.03 Million | 46.88 Million | 4.52 Million | 41.41 Million |
| Other Investing Activities | 959 Thousand | -33.08 Million | 6.59 Million | -18.23 Million | 3.23 Million | -14.88 Million |
| Financing Cash Flow | -309.2 Million | -1.38 Billion | 1.09 Billion | -644.23 Million | -94.72 Million | -1.04 Billion |
| Debt repayment | -20.18 Million | -1.17 Billion | -1.18 Billion | -72.56 Million | -76.49 Million | -1.06 Billion |
| Dividends payments | -324.49 Million | -41.58 Million | -50.36 Million | -349.36 Million | -349.36 Million | -187.93 Million |
| Common Stock Repurchased | 189.92 Million | -189.92 Million | - | -70.99 Million | -70.99 Million | 9.41 Million |
| Common Stock Issuance | - | - | - | - | - | -9.41 Million |
| Other Financing Activities | -4.89 Million | -9.14 Million | -94.91 Million | -147.95 Million | -122.53 Million | 208.46 Million |
| Accounts receivables | - | - | - | 269.49 Million | 269.49 Million | 109.69 Million |
| Accounts payables | - | - | - | 19.98 Million | - | 31.94 Million |
| Inventory | - | - | - | -140.05 Million | -140.05 Million | 80.13 Million |
| Other working capital | - | - | - | -487.73 Thousand | -487.73 Thousand | -31.94 Million |
| Cash at beginning of period | 1.53 Billion | 2.83 Billion | 1.34 Billion | 1.36 Billion | 1.08 Billion | 1.89 Billion |
| Cash at end of period | 1.39 Billion | 1.59 Billion | 2.83 Billion | 1.34 Billion | 1.34 Billion | 1.05 Billion |
| Capital Expenditure | -345.3 Million | -310.68 Million | -478.28 Million | -1.59 Billion | -337.33 Million | -324.4 Million |
| Effect of forex changes on cash | -43.1 Million | 32.79 Million | 10.97 Million | 28.99 Million | -65.72 Million | -17.98 Million |
| Net cash flow / Change in cash | -142.62 Million | -1.24 Billion | 1.49 Billion | -20.86 Million | 252.47 Million | -838.25 Million |
| Free Cash Flow | 234.3 Million | 133.89 Million | 375.33 Million | 624.63 Million | 427.96 Million | 236.67 Million |
688076
601326
BEDMUTHA
688425
SSR
6615